• scleroderma
An Irreversible Covalent Bruton's Tyrosine Kinase Inhibitor Shows Promising Results in Rheumatoid Arthritis Patients with Methotrexate Resistance: Phase IIa Trial Findings
Canakinumab Is Now Indicated for Adult-Onset Still's Disease
CVD Risk in Inflammatory Joint Disease Is Underestimated
EMA Releases New Guide on Biosimilar Medicine
Less Myocardial Infarction in RA Patients Treated with TNF inhibitors
No Benefits for Intensive over Symptomatic Bisphosphonate Treatment in Paget's Disease
Off-Label Prescription Drugs Use in Pediatric Rheumatology
Risk of Myopathy in Gout Patients Taking Colchicine and Statins
Romosozumab Reduces the Risk of Fracture but May Increase CV risk
Sifalimumab May Be Useful in Refractory to Therapy Systemic Lupus Erythematosus
The rationale for use of anti-rheumatic drugs for the management of COVID-19 patients
The Risk for Second Cancer in RA Patients Treated with Biologics